SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy Inc. is trending as community debates the potential impact of earnings on the stock, especially its correlation to Bitcoin's price movements. Discussions include speculation on a possible short squeeze above a certain price point and its potential to trigger a gamma event, while some traders are pointing out that the company's market cap far exceeds its revenue. Amidst volatile overnight trading, the stock is being discussed in relation to its potential S&P 500 inclusion.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending after a strong earnings report driven by AWS and advertising growth, leading to significant after-hours gains. The community is discussing potential upgrades and a possible run to new all-time highs, while also analyzing the impact of the earnings on the broader market and the tech sector. Some are cautious, anticipating a sell-off like Google experienced, while others are optimistic about Amazon's potential in AI and cloud services.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple's earnings are driving mixed sentiments, with initial reactions focusing on strong holiday quarter guidance despite some concerns about iPhone sales and revenue in China. Community discussions revolve around the stock's valuation, potential for growth, and whether the post-earnings gains are sustainable. Some traders are eyeing short-term opportunities, while others maintain a long-term bullish outlook on the tech giant.

UP AND TO THE RIGHT

UPRIGHT CRYPTO is gaining attention for its consistent chart patterns and strong community, with many highlighting its disciplined approach and focus on long-term growth. The community emphasizes patience and stability, suggesting that the token is gearing up for a significant move. Discussions revolve around its organic rise and potential for substantial gains as momentum builds.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. It provides online news services where users can select and rank web content. The firm also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit's stock is trending as investors digest its latest earnings report, which exceeded expectations. Community discussions revolve around the company's revenue growth and user metrics, while some traders express concerns about competition and advertising challenges. Anticipation is building regarding potential analyst upgrades and the stock's ability to sustain its upward momentum.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX is trending as investors digest recent earnings and future growth prospects for IBSRELA and XPHOZAH, particularly as a new pipeline asset is being developed. Community members are actively discussing revenue potential, pipeline optionality, and patent protection. The stock's movement is also influenced by broader discussions around the renal and biopharmaceutical sectors.

Solid Power, Inc. engages in the manufacture and supply of power batteries. The firm develops all solid state battery cell technology that replaces the liquid or gel polymer electrolyte used in conventional lithium-ion battery cells with a sulfide-based solid electrolyte. It focuses on the development and commercialization of all solid state battery cells and solid electrolyte materials, primarily for the battery-powered electric vehicle market. The company was founded on August 3, 2011 and is headquartered in Louisville, CO.

Solid Power Inc

Solid Power Inc - Ordinary Shares - Class A

Solid Power ($SLDP) is trending after announcing a joint evaluation agreement with Samsung and BMW to advance all-solid-state battery technology, sparking excitement about its potential in the EV sector. The community is actively discussing the implications of this partnership, with some speculating about warrant values and future announcements. While some compare Solid Power to competitors like QuantumScape, bullish sentiment is building around the company's progress and partnerships.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as the community discusses potential buyout offers following competitor acquisitions in the obesity drug space, especially with upcoming presentations at ObesityWeek. Community talking points include speculation on potential acquirers and the value of VKTX's pipeline, particularly its oral and injectable GLP-1/GIP therapies, relative to recent deals. Bullish sentiment is fueled by analysts initiating coverage with buy ratings and high price targets.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is trending amid speculation of a potential acquisition, with SpaceX named as a possible suitor, driving community discussion around the implications for Apple, a key partner.  Investors are weighing the potential value of Globalstar's spectrum and existing partnerships, especially as earnings approach and strategic scenarios, such as a bidding war, are considered.  The surge in interest reflects the broader race for satellite communication dominance and the strategic importance of spectrum assets.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

META is trending as the community debates its future after a significant dip following earnings, despite strong revenue growth; conversation centers on increased AI spending and a one-time tax charge impacting EPS.  Bulls see a buying opportunity and anticipate a swift recovery, while bears express concerns about capital expenditure and potential market manipulation. A massive bond sale is being interpreted by some as a sign of institutional confidence.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Investors focused on Dexcom’s lower gross margin of 61.3%, down about 170 basis points year-over-year, despite record revenue and earnings.</li><li>The company said elevated scrap and freight costs would continue to pressure margins in the near term, even as efficiency improvements are underway.</li><li>Some retail traders viewed the decline as a buying opportunity, calling the after-hours drop “uncalled for.”&nbsp;</li></ul>Dexcom shares slid 13% in after-hours trading on Thursday, as investors looked past a record third-quarter (Q3) profit and focused instead on rising costs and a cautious outlook for next year.The glucose monitoring company reported $1.21 billion in revenue for Q3, up 22% year over year, driven by strong demand across the U.S. and international markets. Net income jumped to $242.5 million, or $0.61 per share, its highest ever.Dexcom also raised its full-year revenue forecast to $4.63-$4.65 billion, representing around 15% growth. However, the company’s upbeat sales&nbsp;weren’t enough to offset concerns about profitability, as it said gross margins will remain near 61%, down about 170 basis points year over year.<h2 class="st-heading-2">Margin Pressure And Outlook</h2>The company acknowledged that elevated scrap rates and freight costs continued to eat into profits. Management said the hit was “roughly half and half” between manufacturing waste and shipping expenses, though both are expected to ease gradually in the coming quarters.Looking ahead, Dexcom projected double-digit revenue growth in 2026, but slightly below Wall Street’s expectations. The forecast does not yet include potential benefits from broader insurance coverage for type 2 diabetes patients, which the company said could provide upside later on.Dexcom added that its new 15-day G7 sensor, currently rolling out to users, will have a limited impact this year but should meaningfully boost margins and growth in 2026 once it gains wider reimbursement.<h2 class="st-heading-2">Growth Drivers Remain Intact</h2>Despite the market reaction, Dexcom’s underlying growth story remains strong. The company continues to expand its reach in the type 2 diabetes market, now covering nearly 6 million non-insulin patients in the U.S.International revenue grew 22%, led by strong momentum in France and Canada following new reimbursement coverage. Its consumer-focused continuous glucose monitor, Stelo, topped $100 million in sales within its first year, with plans to launch in more markets in 2026. Dexcom ended the quarter with over $3.3 billion in cash.<h2 class="st-heading-2">Stocktwits Traders Stay Bullish Despite Selloff</h2>On Stocktwits, retail sentiment for Dexcom was ‘extremely bullish’ amid a 921% surge in 24-hour message volume.<figure class="image"><img style="aspect-ratio:959/126;" src="https://news.stocktwits-cdn.com/dxcm_ss_jpg_7ecd09626d.webp" alt="dxcm ss.jpg" width="959" height="126"><figcaption>DXCM sentiment and message volume as of October 30 | Source: Stocktwits</figcaption></figure>One user said the market reaction reflected disappointment that the company’s longtime executive, now CEO, had signaled that Wall Street’s expectations for 2026 growth were too high, while also acknowledging a slowdown in new patient starts.<stembedurl>https://stocktwits.com/freddycan/message/634416837</stembedurl>Another user said they hoped analysts would issue more bullish reports and raise price targets, describing the selloff as “uncalled for.”<stembedurl>https://stocktwits.com/longshortequities/message/634409824</stembedurl>A third user took the opposite stance, calling the pullback a buying opportunity.<stembedurl>https://stocktwits.com/Okadarlan/message/634408938</stembedurl><a href="https://stocktwits.com/symbol/DXCM">Dexcom’s stock</a> has declined 12% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the DexCom logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Dexcom Stock Plunges 13% After-Hours As Q3 Margin Pressures Eclipse Record Profit — Retail Sees ‘Buy The Dip’ Setup

Investors focused on Dexcom’s lower gross margin of 61.3%, down about 170 basis points year-over-year, despite record revenue and earnings.

Equity

DexCom (DXCM) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for DexCom (DXCM) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

DexCom (DXCM) Surpasses Q3 Earnings and Revenue Estimates

DexCom (DXCM) delivered earnings and revenue surprises of +7.02% and +2.72%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Dexcom Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Guidance

DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights: Revenue grew 22% year-over-year to $1.209...

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DexCom, Inc. (DexCom or the Company) (NASDAQ: DXCM) for violations of 10(b) and...

Insights Into DexCom (DXCM) Q3: Wall Street Projections for Key Metrics

Beyond analysts' top-and-bottom-line estimates for DexCom (DXCM), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit PR Newswire NEW YORK, Oct. 28, 2025 NEW...

DCXM ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of DexCom, Inc. Investors

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired DexCom, Inc. (DexCom or the Company) (NASDAQ:DXCM) securities during the...

Rosen Law Firm Urges DexCom, Inc. (NASDAQ: DXCM) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of DexCom, Inc. (NASDAQ: DXCM) securities between...

<ul class="summary-bullets"><li>Short seller Hunterbrook flagged three new deaths linked to the Dexcom G7 reported in&nbsp;the FDA MAUDE database.</li><li>It stated that at least 13 G7 users have died since the device launched in 2023.&nbsp;</li><li>This is&nbsp;the second time the firm has published data around Dexcom, after first disclosing its short position in September.</li></ul>Dexcom (DXCM) shares slipped in midday trade on Tuesday after short seller Hunterbrook reported three additional deaths linked to the company’s G7 continuous glucose monitor.<a href="http://stocktwits.com/symbol/DXCM">DXCM’s stock</a> fell nearly 2%, with retail sentiment on Stocktwits around the company trending in ‘bearish’ territory over the past day.&nbsp; Hunterbrook first&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/dexcom-stock-slumps-after-hunterbrook-media-investigation-raises-concerns-about-its-g7-device/chD3f5NR3Tm">disclosed</a> its short position in September, citing inaccurate G7 readings that allegedly sent patients to ICUs or&nbsp;led to worse outcomes.&nbsp;<h2 class="st-heading-2">FDA Data Shows Device Risks</h2>The short seller&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://hntrbrk.com/dexcom2/">said</a> the new deaths were documented in the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database, which tracks adverse events involving medical devices. It noted that while the reports do not necessarily prove the device caused the deaths, they help regulators and manufacturers flag potential risks.Hunterbook highlighted that one report described a 69-year-old man whose G7 sensor failed to provide readings, and a second involved a patient using the G7 with an automated insulin pump, whose inaccurate reading may have contributed to fatal ketoacidosis. The third report cited a woman who relied on the G7’s receiver alarms, which had been recalled days earlier for failing to sound properly.<h2 class="st-heading-2">Ongoing Scrutiny And Product Concerns</h2>The short seller stated that at least 13 G7 users have died since the device launched in 2023.&nbsp;It said that even the FDA issued a warning letter to Dexcom in March 2025 following a surprise inspection that revealed unauthorized design changes to a key component, which internal testing found inferior.&nbsp;Dexcom reportedly continued selling the device despite these findings. The short seller stated that the resulting controversy has triggered executive departures, insider selling, and patients returning to older G6 devices or switching to competitors, while ongoing lawsuits and regulatory scrutiny weigh on the company.DXCM’s stock has declined 11% this year and more than 8% since Hunterbrook first disclosed its short position.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/bitcoin-holds-near-114-k-ahead-of-fed-rate-decision-sol-xrp-edge-higher/cLGjgObR3H9">Bitcoin Holds Near $114K Ahead of Fed Rate Decision — SOL, XRP Edge Higher</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of stock price falling. (Photo by Yuichiro Chino/Getty Images)

Dexcom Shares Slide After Short Seller Flags 3 Additional Deaths From G7 Devices

Short seller Hunterbrook stated that at least 13 G7 users have died since the device launched in 2023. 

$DXCM Q3 &#39;25 Earnings Results &amp; Recap

Dexcom reported Q3 2025 revenue of $1.21B versus estimates of $1.18B and EPS of $0.61 versus estimates of $0.57, while raising revenue guidance to $4.63B-$4.65B, but lowering gross margin guidance to approximately 61%.

Stocktwits

Dexcom Inc

 Q3 '25 Earnings Results & Recap

Dexcom reported Q3 2025 revenue of $1.21B versus estimates of $1.18B and EPS of $0.61 versus estimates of $0.57, while raising revenue guidance to $4.63B-$4.65B, but lowering gross margin guidance to approximately 61%.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Will Amazon.com ($AMZN) beat quarterly earnings? 
 
*Powered by Polymarket

Free shipping on millions of items. Get the best of Shopping and Entertainment with Prime. Enjoy low prices and great deals on the largest selection of everyday essentials and other products, including fashion, home, beauty, electronics, Alexa Devices, sporting goods, toys, automotive, pets, baby, books, video games, musical instruments, office supplies, and more.

Amazon

Amazon.com. Spend less. Smile more.

) beat quarterly earnings? 
 
*Powered by Polymarket

DXCM
Dexcom Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Earnings Recap

Latest DXCM News

DXCMDexcom Inc